Why it matters
Blood thinners change the safety conversation
Blood thinners include anticoagulants and antiplatelet medicines that lower clotting risk but can raise bleeding risk. Peptide therapy may still be possible for some patients, but the decision depends on the reason for the blood thinner, recent bleeding or clotting events, procedures, kidney or liver function, and the exact product being considered.
- Warfarin patients may have INR monitoring or diet and medication changes that should not be disrupted by weight-loss, supplement, or wellness programs.
- People using direct oral anticoagulants or antiplatelet drugs should still disclose kidney function, procedure plans, falls, bleeding symptoms, and all OTC products.
- A telehealth intake should not treat “blood thinner” as a single checkbox; the medication name and reason for use matter.